Harvest One Provides An Update On Dream Water® On The Occasion of World Sleep Day 2019 Cannabis Investing News
NervGen Pharma Completes $10 Million Initial Public Offering; Shares to Commence Trading on TSX-V on March 15, 2019 – Symbol “NGEN” Pharmaceutical Investing
Checkpoint Therapeutics Announces Issuance of Two New Patents for EGFR Inhibitor CK-101 Biotech Investing
Auris Medical Announces Publication of AM-111 Phase 3 Results in Peer-Reviewed Scientific Journal Biotech Investing
PreveCeutical Announces Preliminary Screening Results of Peptides Derived From Blue Scorpion Venom in a Cell-Based Brain Cancer Model Pharmaceutical Investing
TG Therapeutics Announces Positive Data Safety Monitoring Board Reviews of UNITY-CLL and UNITY-NHL Clinical Trials Biotech Investing
AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena Pharmaceutical Investing
